KRas, ROS and the initiation of pancreatic cancer

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197 · see citing works

Reactive oxygen species in cancer

Liou, G., & Störz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,394 · see citing works

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277 · see citing works

Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway

Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990 · see citing works

Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity

Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742 · see citing works

NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer

Hayes, J. D., & McMahon, M. J. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.12.008 · Cited by 870 · see citing works

Ras Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species

Lee, A. C., Fenster, B. E., Ito, H., Takeda, K., Bae, N. S., Hirai, T., Yu, Z.-X., Ferrans, V. J., Howard, B. H., & Finkel, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7936 · Cited by 691 · see citing works

EGF Receptor is Required for KRAS-induced Pancreatic Tumorigenesis

Ardito, C. M., Grüner, B., Takeuchi, K. K., Lubeseder-Martellato, C., Teichmann, N., Mazur, P., DelGiorno, K. E., Carpenter, E. S., Halbrook, C., Hall, J. C., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.024 · Cited by 522 · see citing works

Intracellular Reactive Oxygen Species Activate Src Tyrosine Kinase during Cell Adhesion and Anchorage-Dependent Cell Growth

Giannoni, E., Buricchi, F., Raugei, G., Ramponi, G., & Chiarugi, P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6391-6403.2005 · Cited by 455 · see citing works

Mitochondria as biosynthetic factories for cancer proliferation

Ahn, C. S., & Metallo, C. M. (2015) · Cancer & Metabolism · doi:10.1186/s40170-015-0128-2 · Cited by 399 · see citing works

EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal Adenocarcinoma

Navas, C., Hernández-Porras, I., Schuhmacher, A. J., Sibilia, M., Guerra, C., & Barbacid, M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.001 · Cited by 391 · see citing works

Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation

Ogrunc, M., Di Micco, R., Liontos, M., Bombardelli, L., Mione, M., Fumagalli, M., Gorgoulis, V. G., & d'Adda di Fagagna, F. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.16 · Cited by 328 · see citing works

Protein kinase D mediates a stress‐induced NF‐κB activation and survival pathway

Störz, P., & Toker, A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdg009 · Cited by 325 · see citing works

Functions and Mechanisms of Redox Regulation of Cysteine-Based Phosphatases

Salmeen, A. E., & Barford, D. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.560 · Cited by 312 · see citing works

K-rasG12V transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis

Hu, Y., Lu, W., Chen, G., Wang, P., Chen, Z., Zhou, Y., Ogasawara, M. A., Trachootham, D., Feng, L., Pelicano, H., et al. (2011) · Cell Research · doi:10.1038/cr.2011.145 · Cited by 306 · see citing works

Positive Contribution of Pathogenic Mutations in the Mitochondrial Genome to the Promotion of Cancer by Prevention from Apoptosis

Shidara, Y., Yamagata, K., Kanamori, T., Nakano, K., Kwong, J. Q., Manfredi, G., Oda, H., & Ohta, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2012 · Cited by 284 · see citing works

Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions

Liou, G.-Y., Döppler, H., DelGiorno, K. E., Zhang, L., Leitges, M., Crawford, H. C., Murphy, M. P., & Storz, P. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.029 · Cited by 270 · see citing works

Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice

Maniati, E., Bossard, M., Cook, N., Candido, J. B., Emami-Shahri, N., Nedospasov, S. A., Balkwill, F. R., Tuveson, D. A., & Hagemann, T. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45797 · Cited by 249 · see citing works

Protein Kinase D Mediates Mitochondrion-to-Nucleus Signaling and Detoxification from Mitochondrial Reactive Oxygen Species

Störz, P., Döppler, H. R., & Toker, A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.19.8520-8530.2005 · Cited by 237 · see citing works

Role of Growth Factors in Pancreatic Cancer

Korc, M. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30283-7 · Cited by 234 · see citing works

Protein Kinase Cδ Selectively Regulates Protein Kinase D-Dependent Activation of NF-κB in Oxidative Stress Signaling

Störz, P., Döppler, H. R., & Toker, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2614-2626.2004 · Cited by 227 · see citing works

Involvement of Autophagy in Oncogenic K-Ras-induced Malignant Cell Transformation

Kim, M. J., Woo, S.-J., Yoon, C., Lee, J., An, S., Choi, Y. H., Hwang, S., Yoon, G., & Lee, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.138958 · Cited by 225 · see citing works

Molecular Pathology of Pancreatic Cancer

Wood, L. D., Adsay, V. N., & Hruban, R. H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4900-3_2 · Cited by 182 · see citing works

Oncogenic K-Ras requires activation for enhanced activity

Huang, H., Daniluk, J., Liu, Y., Chu, J., Li, Z., Ji, B., & Logsdon, C. D. (2013) · Oncogene · doi:10.1038/onc.2012.619 · Cited by 139 · see citing works

Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells

Lee, K., & Bar-Sagi, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.020 · Cited by 134 · see citing works

Nuclear Factor-κB p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells

Pan, X., Arumugam, T., Yamamoto, T., Levin, P. A., Ramachandran, V., Ji, B., Lopez‐Berestein, G., Vivas‐Mejía, P. E., Sood, A. K., McConkey, D. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1539 · Cited by 129 · see citing works

Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer

Wang, P., Zhu, C.-F., Ma, M.-Z., Chen, G., Song, M., Zeng, Z.-L., Lu, W.-H., Yang, J., Wen, S., Chiao, P. J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4125 · Cited by 122 · see citing works

KRas Induces a Src/PEAK1/ErbB2 Kinase Amplification Loop That Drives Metastatic Growth and Therapy Resistance in Pancreatic Cancer

Kelber, J. A., Reno, T. A., Kaushal, S., Metildi, C. A., Wright, T., Stoletov, K. V., Weems, J. M., Park, F. D., Mose, E. S., Wang, Y., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3552 · Cited by 113 · see citing works

Transferrin receptor regulates pancreatic cancer growth by modulating mitochondrial respiration and ROS generation

Jeong, S. M., Hwang, S., & Seong, R. H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.023 · Cited by 112 · see citing works

Oncogenic KRAS modulates mitochondrial metabolism in human colon cancer cells by inducing HIF-1α and HIF-2α target genes

Chun, S. Y., Johnson, C., Washburn, J. G., Cruz-Correa, M. R., Dang, D. T., & Dang, L. H. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-293 · Cited by 109 · see citing works

Protein kinase D1 drives pancreatic acinar cell reprogramming and progression to intraepithelial neoplasia

Liou, G., Döppler, H. R., Braun, U. B., Panayiotou, R., Scotti, M. L., Radisky, D. C., Crawford, H. C., Fields, A. P., Murray, N. R., Wang, Q. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms7200 · Cited by 104 · see citing works

Antioxidant Status and Oxidative Stress Markers in Pancreatic Cancer and Chronic Pancreatitis

Kodydková, J., Vávřová, L., Staňková, B., Macášek, J., Krechler, T., & Žák, A. (2013) · Pancreas · doi:10.1097/mpa.0b013e318288360a · Cited by 89 · see citing works

Deletion of Rb Accelerates Pancreatic Carcinogenesis by Oncogenic Kras and Impairs Senescence in Premalignant Lesions

Carrière, C., Gore, A. J., Norris, A. M., Gunn, J. R., Young, A. L., Longnecker, D. S., & Korc, M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.05.041 · Cited by 76 · see citing works

Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels

Kong, B., Qia, C., Erkan, M., Kleeff, J. H., & Michalski, C. W. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00246 · Cited by 72 · see citing works

When antioxidants are bad

Perera, R. M., & Bardeesy, N. M. (2011) · Nature · doi:10.1038/475043a · Cited by 71 · see citing works

Oncogenic Ras/Src cooperativity in pancreatic neoplasia

Shields, D. J., Murphy, E. A., Desgrosellier, J. S., Mielgo, A., Lau, S. K. M., Barnes, L. A., Lesperance, J., Huang, M., Schmedt, C., Tarin, D., et al. (2011) · Oncogene · doi:10.1038/onc.2010.589 · Cited by 64 · see citing works

Ras-induced ROS upregulation affecting cell proliferation is connected with cell type-specific alterations of HSF1/SESN3/p21Cip1/WAF1pathways

Zamkova, M. A., Хромова, Н. В., Kopnin, B. P., & Kopnin, P. (2013) · Cell Cycle · doi:10.4161/cc.23723 · Cited by 56 · see citing works

Deletion of Pim kinases elevates the cellular levels of reactive oxygen species and sensitizes to K-Ras-induced cell killing

Song, J. H., An, N., Chatterjee, S., Kistner‐Griffin, E., Mahajan, S., Mehrotra, S., & Kraft, A. S. (2014) · Oncogene · doi:10.1038/onc.2014.306 · Cited by 48 · see citing works

Oxidative Stress Induced by Inactivation of TP53INP1 Cooperates with KrasG12D to Initiate and Promote Pancreatic Carcinogenesis in the Murine Pancreas

Saati, T. A., Clerc, P., Hanoun, N., Peuget, S., Lulka, H., Gigoux, V., Capilla, F., Béluchon, B., Couvelard, A., Sèlves, J., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.034 · Cited by 46 · see citing works

Downregulation of TRAF2 Mediates NIK-Induced Pancreatic Cancer Cell Proliferation and Tumorigenicity

Döppler, H. R., Liou, G., & Störz, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053676 · Cited by 45 · see citing works

Mitochondrial Oxidative Stress-Induced Epigenetic Modif ications in Pancreatic Epithelial Cells

Mishra, P. K., Raghuram, G. V., Jain, D. K., Jain, S. K., Khare, N. K., & Pathak, N. (2014) · International Journal of Toxicology · doi:10.1177/1091581814524064 · Cited by 35 · see citing works

Pancreatic oncogenic signaling cascades converge at Protein Kinase D1

Liou, G., Leitges, M., & Störz, P. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1032646 · Cited by 2 · see citing works

Understanding of ROS-Inducing Strategy in Anticancer Therapy

Kim, S. J., Kim, H. S., & Seo, Y. R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5381692 · Cited by 404 · see citing works

Energy metabolism in health and diseases

Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 438 · see citing works

Cell death in pancreatic cancer: from pathogenesis to therapy

Chen, X., Zeh, H. J., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00486-6 · Cited by 338 · see citing works

Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies

Kalyanaraman, B., Cheng, G., Hardy, M., Ouari, O., Bennett, B., & Zielonka, J. (2017) · Redox Biology · doi:10.1016/j.redox.2017.12.012 · Cited by 222 · see citing works

Regulation of Nrf2/ARE Pathway by Dietary Flavonoids: A Friend or Foe for Cancer Management?

Suraweera, T. L., Rupasinghe, H. P. V., Dellaire, G., & Xu, Z. (2020) · Antioxidants · doi:10.3390/antiox9100973 · Cited by 207 · see citing works

Breast Cancer Subtypes Present a Differential Production of Reactive Oxygen Species (ROS) and Susceptibility to Antioxidant Treatment

Sarmiento-Salinas, F. L., Delgado-Magallón, A., Montes-Alvarado, J. B., Ramírez-Ramírez, D., Flores-Alonso, J. C., Cortés-Hernández, P., Reyes‐Leyva, J., Camacho, I. H., Anaya-Ruı́z, M., Pelayo, R., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00480 · Cited by 180 · see citing works

KRAS Controls Pancreatic Cancer Cell Lipid Metabolism and Invasive Potential through the Lipase HSL

Rozeveld, C. N., Johnson, K. M., Zhang, L., & Razidlo, G. L. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1255 · Cited by 162 · see citing works

Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy

Shi, Y., Wang, Y., Dong, H., Niu, K., Zhang, W., Feng, K., Yang, R., & Zhang, Y. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01868-8 · Cited by 123 · see citing works

Ferroptosis: Final destination for cancer?

Zeng, Y., Liu, W., Zhuo, Q., Hu, Q., Liu, M., Sun, Q., Zhang, Z., Fan, G., Xu, W., Ji, S., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12761 · Cited by 115 · see citing works

Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer

Stefanoudakis, D., Frountzas, M., Schizas, D., Michalopoulos, N. V., Drakaki, A., & Toutouzas, K. G. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46040177 · Cited by 110 · see citing works

Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review

Koltai, T., Reshkin, S. J., Carvalho, T. M. A., Molfetta, D. D., Greco, M. R., Alfarouk, K. O., & Cardone, R. A. (2022) · Cancers · doi:10.3390/cancers14102486 · Cited by 107 · see citing works

The Mechanism of Ferroptosis and Applications in Tumor Treatment

Lin, X., Ping, J., Wen, Y., & Wu, Y. R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01061 · Cited by 104 · see citing works

ROS and TGFβ: from pancreatic tumour growth to metastasis

Chang, C., & Pauklin, S. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01960-4 · Cited by 100 · see citing works

Inflammation and pancreatic cancer: An updated review

Shadhu, K., & Xi, C. (2018) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_390_18 · Cited by 94 · see citing works

Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics

Murthy, D., Attri, K. S., & Singh, P. K. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00335 · Cited by 92 · see citing works

Zooming in and out of ferroptosis in human disease

Wang, X., Zhou, Y., Min, J., & Wang, F. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-0992-z · Cited by 83 · see citing works

Targeting reactive oxygen species in development and progression of pancreatic cancer

Durand, N., & Störz, P. (2016) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2017.1261017 · Cited by 78 · see citing works

Targeting Redox Metabolism in Pancreatic Cancer

Hadi, N. A., Reyes‐Castellanos, G., & Carrier, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041534 · Cited by 62 · see citing works

Overview of Cancer Metabolism and Signaling Transduction

Chae, H., & Hong, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010012 · Cited by 63 · see citing works

The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells

Fu, Y., Ricciardiello, F., Yang, G., Qiu, J., Huang, H., Xiao, J., Cao, Z., Zhao, F., Liu, Y., Luo, W., et al. (2021) · Cells · doi:10.3390/cells10030497 · Cited by 57 · see citing works

Sustained IKKβ phosphorylation and NF-κB activation by superoxide-induced peroxynitrite-mediated nitrotyrosine modification of B56γ3 and PP2A inactivation

Yee, Y. H., Chong, S. J. F., Kong, L. R., Goh, B. C., & Pervaiz, S. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101834 · Cited by 47 · see citing works

The Role of ROS as a Double-Edged Sword in (In)Fertility: The Impact of Cancer Treatment

Mendes, S., Sá, R., Ferreira‐Magalhães, M., Marques, F., Sousa, M., & Silva, E. (2022) · Cancers · doi:10.3390/cancers14061585 · Cited by 45 · see citing works

Mitochondrial and Oxidative Stress-Mediated Activation of Protein Kinase D1 and Its Importance in Pancreatic Cancer

Döppler, H. R., & Störz, P. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00041 · Cited by 40 · see citing works

Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma

Kuang, Y., Sechi, M., Nurra, S., Ljungman, M. E., & Neamati, N. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01463 · Cited by 39 · see citing works

Combinatorial Effects of the Natural Products Arctigenin, Chlorogenic Acid, and Cinnamaldehyde Commit Oxidation Assassination on Breast Cancer Cells

Schuster, C., Wolpert, N., Moustaïd‐Moussa, N., & Gollahon, L. (2022) · Antioxidants · doi:10.3390/antiox11030591 · Cited by 35 · see citing works

Acinar to ductal cell trans-differentiation: A prelude to dysplasia and pancreatic ductal adenocarcinoma

Parte, S. C., Nimmakayala, R. K., Batra, S. K., & Ponnusamy, M. P. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188669 · Cited by 33 · see citing works

NOX4 links metabolic regulation in pancreatic cancer to endoplasmic reticulum redox vulnerability and dependence on PRDX4

Jain, P., Dvorkin‐Gheva, A., Mollen, E., Malbeteau, L., Xie, M. H., Jessa, F., Dhavarasa, P., Chung, S., Brown, K. R., Jang, G. H., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf7114 · Cited by 32 · see citing works

Reactive Oxygen Species and Oncoprotein Signaling-A Dangerous Liaison

Chong, S. J. F., Lai, J. X. H., Eu, J. Q., Bellot, G. L., & Pervaiz, S. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7441 · Cited by 30 · see citing works

Polyphenols as Possible Agents for Pancreatic Diseases

Gašić, U. M., Ćirić, I. Ž., Pejcic, T. P., Radenkovic, D. V., Djordjevic, V. R., Radulovic, S. S., & Tešić, Ž. (2020) · Antioxidants · doi:10.3390/antiox9060547 · Cited by 30 · see citing works

The high expression of MTH1 and NUDT5 predict a poor survival and are associated with malignancy of esophageal squamous cell carcinoma

Wang, J., Liu, T., Li, J., Li, D., Tian, X.-Y., Ouyang, Q.-G., & Cai, J. (2020) · PeerJ · doi:10.7717/peerj.9195 · Cited by 27 · see citing works

Cyclophosphamide‐Induced Infertility and the Impact of Antioxidants

Abdi, M., Fadaee, M., Jourabchi, A., Karimzadeh, H., & Kazemi, T. (2024) · American Journal of Reproductive Immunology · doi:10.1111/aji.70014 · Cited by 28 · see citing works

Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer

Zhang, Y., Liang, S., Zhao, L., Yang, H., Marti, T. M., Hegedűs, B., Gao, Y., Zheng, B., Chen, C., Wang, W., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02240-5 · Cited by 26 · see citing works

Responsive Nanomaterial Delivery Systems for Pancreatic Cancer Management

Elsherbeny, A., Bayraktutan, H., Öz, U. C., Moloney, C., Ashworth, J., Grabowska, A. M., & Alexander, C. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300330 · Cited by 25 · see citing works

Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS‐mutant cancer

Zhang, Y., Liang, S., Saliakoura, M., Yang, H., Vassella, E., Konstantinidou, G., Tschan, M. P., Hegedűs, B., Zhao, L., Gao, Y., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013193 · Cited by 23 · see citing works

Paradoxical Role of AT-rich Interactive Domain 1A in Restraining Pancreatic Carcinogenesis

Ferri-Borgogno, S., Barui, S., McGee, A. M., Griffiths, T., Singh, P. K., Piett, C. G., Ghosh, B., Bhattacharyya, S., Singhi, A., Pradhan, K., et al. (2020) · Cancers · doi:10.3390/cancers12092695 · Cited by 22 · see citing works

MicroRNA Targeting Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Cancer

Kushwaha, P. P., Gupta, S., Singh, A. K., Prajapati, K. S., Shuaib, M., & Kumar, S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7918 · Cited by 22 · see citing works

Single-PanIN-seq unveils that ARID1A deficiency promotes pancreatic tumorigenesis by attenuating KRAS-induced senescence

Liu, S., Cao, W., Niu, Y., Luo, J., Zhao, Y., Hu, Z., & Zong, C. C. (2021) · eLife · doi:10.7554/elife.64204 · Cited by 21 · see citing works

Tephrosin induces apoptosis of human pancreatic cancer cells through the generation of reactive oxygen species

Du, J., Jiang, F., Xu, S.-S., Huang, Z., Chen, L., & Li, L. (2020) · Journal of Cancer · doi:10.7150/jca.50360 · Cited by 20 · see citing works

Targeting mitochondrial dysfunctions in pancreatic cancer evokes new therapeutic opportunities

Sarwar, A., Zhu, M., Su, Q., Zhu, Z., Yang, T., Chen, Y., Peng, X., & Zhang, Y. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103858 · Cited by 20 · see citing works

KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations.

Zhang, X., Zhang, R., Chen, H., Wang, L., Ren, C., Pataer, A., Wu, S., Meng, Q. H., Ha, M. J., Morris, J. S., et al. (2020) · PubMed Central · Cited by 20 · see citing works

Oncogenic KRAS and the EGFR loop in pancreatic carcinogenesis—A connection to licensing nodes

Schneeweis, C., Wirth, M., Saur, D., Reichert, M., & Schneider, G. (2016) · Small GTPases · doi:10.1080/21541248.2016.1262935 · Cited by 20 · see citing works

Circulating gamma‐glutamyl transpeptidase and risk of pancreatic cancer: A prospective cohort study in the UK Biobank

Liao, W., Yu, Y., Yang, H., Qu, Y., Song, H., & Li, Q. (2022) · Cancer Medicine · doi:10.1002/cam4.5556 · Cited by 15 · see citing works

Inhibition of the PI3K/AKT/mTOR pathway in pancreatic cancer: is it a worthwhile endeavor?

Jarroudi, O. A., Chibani, H., Brahmi, S. A., & Said, A. (2024) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359241284911 · Cited by 17 · see citing works

Senescence program and its reprogramming in pancreatic premalignancy

Yang, K., Li, X., & Xie, K. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06040-3 · Cited by 16 · see citing works

Iron-Dependent Cell Death: A New Treatment Approach against Pancreatic Ductal Adenocarcinoma

Lopez-Blazquez, C., Lacalle-González, C., Sanz-Criado, L., Otieno, M. O., García‐Foncillas, J., & Martínez‐Useros, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914979 · Cited by 15 · see citing works

Protective Effect of an Isoflavone, Tectorigenin, Against Oxidative Stress-induced Cell Death via Catalase Activation

Zhang, R., Piao, M. J., Oh, M. C., Park, J. E., Shilnikova, K., Moon, Y. J., Kim, D., Jung, U., Kim, I. G., & Hyun, J. W. (2016) · Journal of Cancer Prevention · doi:10.15430/jcp.2016.21.4.257 · Cited by 13 · see citing works

Novel perspective in pancreatic cancer therapy: Targeting ferroptosis pathway

Yang, Y., Zhang, Z., Wen, Y. C., Xiong, L., Huang, Y.-P., Wang, Y., & Liu, K. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i11.1668 · Cited by 13 · see citing works

From Microenvironment Remediation to Novel Anti-Cancer Strategy: The Emergence of Zero Valent Iron Nanoparticles

Wu, Y., Yang, L., Wang, P., Braet, F., & Shieh, D. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010099 · Cited by 11 · see citing works

EGFR-targeting RNase A-cetuximab antibody-drug conjugate induces ROS-mediated apoptosis to overcome drug resistance in KRAS mutant cancer cells

Jafary, B., Akbarzadeh-Khiavi, M., Farzi-Khajeh, H., Safary, A., & Adibkia, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-85856-9 · Cited by 8 · see citing works

KRAS and NRF2 drive metabolic reprogramming in pancreatic cancer cells: the influence of oxidative and nitrosative stress

Rapozzi, V., Comuzzi, C., Giorgio, E. D., & Xodo, L. E. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1547582 · Cited by 8 · see citing works

Targeted mitochondrial therapy for pancreatic cancer

Zhao, X., Wu, G., Tao, X., Dong, D., & Liu, J. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102340 · Cited by 7 · see citing works

Nuclear factor kappa-B contributes to cigarette smoke tolerance in pancreatic ductal adenocarcinoma through cysteine metabolism

Gunda, V., Chhonker, Y. S., Natesh, N. S., Raut, P., Muniyan, S., Wyatt, T. A., Murry, D. J., Batra, S. K., & Rachagani, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112312 · Cited by 7 · see citing works

Effects of neoadjuvant therapies on genetic regulation of targeted pathways in ER+ primary ductal breast carcinoma: A meta-analysis of microarray datasets

Albogami, S. M., Asiri, Y. A., Asiri, A., Alnefaie, A., & Alnefaie, S. M. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.04.027 · Cited by 6 · see citing works

Bioactive compound D-Pinitol-loaded graphene oxide-chitosan-folic acid nanocomposite induced apoptosis in human hepatoma HepG-2 cells

Ibrahim, I. A. A., Alzahrani, A. R., Alanazi, I. M., Shahzad, N., Shahid, I., Falemban, A. H., Azlina, M. F. N., & Arulselvan, P. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105282 · Cited by 5 · see citing works

Biological activity and computational analysis of novel acrylonitrile derived benzazoles as potent antiproliferative agents for pancreatic adenocarcinoma with antioxidative properties

Beč, A., Persoons, L., Daelemans, D., Starčević, K., Vianello, R., & Hranjec, M. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107326 · Cited by 5 · see citing works

Novel therapeutic strategies and perspectives for pancreatic cancer: Autophagy and apoptosis are key mechanisms to fight pancreatic cancer

Luo, W., Zheng, L., & Zhang, T. T. (2021) · Medical Oncology · doi:10.1007/s12032-021-01522-w · Cited by 5 · see citing works

Oxidative stress and pancreatic cancer: a dual role in tumorigenesis and drug toxicity

Limbu, K. R., Chhetri, R. B., Oh, Y. S., Oak, M., Beak, D. J., & Park, E. (2025) · Toxicological Research · doi:10.1007/s43188-025-00301-3 · Cited by 6 · see citing works

Integrating CRISPR Technology with Key Genetic Markers in Pancreatic Cancer: A New Frontier in Targeted Therapies

Stefanoudakis, D. (2025) · SynBio · doi:10.3390/synbio3010001 · Cited by 4 · see citing works

Cellulose and cellulose derivatives-based nanosystems as therapeutic platform

Wong, L. W., Fahimizadeh, M., & Tan, J. B. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85656-0.00022-x · Cited by 4 · see citing works

A multimodal framework for assessing the link between pathomics, transcriptomics, and pancreatic cancer mutations

Berloco, F., Zaccaria, G. M., Altini, N., Colucci, S., & Bevilacqua, V. (2025) · Computerized Medical Imaging and Graphics · doi:10.1016/j.compmedimag.2025.102526 · Cited by 3 · see citing works

Assessment of the Nutraceutical Properties of Wild Strawberry (Fragaria vesca L.) Extracts on Human Colorectal Cell Lines

Oldani, M., Guzzetti, L., Pioltelli, E., Sala, D., Panzeri, D., Brioschi, M., Forcella, M. E., & Fusi, P. A. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70018 · Cited by 3 · see citing works

Leiomyoma phosphoproteins involved in inhibition of oxidative stress and synthesis of reactive oxygen species

Ura, B., Monasta, L., Arrigoni, G., Licastro, D., Lorenzo, G. D., Romano, F., Gaita, B., Scrimin, F., & Ricci, G. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4377 · Cited by 3 · see citing works

KRAS mutant colon cancer-targeted induction of ferroptosis via photocatalytic activation of BiVO4-embedded silica nano with cascadic downregulation of GPX4/xCT axis

Jiang, Y., Jenjob, R., Ryu, D., Shen, Z., & Yang, S. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.06.024 · Cited by 2 · see citing works

The Impact of Peroxiredoxin 3 on Molecular Testing, Diagnosis, and Prognosis in Human Pancreatic Ductal Adenocarcinoma

Kakehashi, A., Suzuki, S., Nishidoi, Y., Hagihara, A., Ikenaga, H., Shiota, M., Qiu, G., Noura, I., Kuwae, Y., Vachiraarunwong, A., et al. (2025) · Cancers · doi:10.3390/cancers17132212 · Cited by 2 · see citing works

Downregulation of Sod2 increases atypical flat lesions and dysplasia to advance pancreatic ductal adenocarcinoma

Martinez, A. K. F., Döppler, H. R., Argo, R. A., Bastea, L. I., Edenfield, B. H., Espositio, I., & Störz, P. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02518-0 · Cited by 1 · see citing works

Emerging Interdisciplinary Techniques to Extend ROS Modulation for the Benefit of Chemo-/Radiotherapy in Cancer

Singh, S., Dhankhar, R., Dhull, A. K., & Dahiya, K. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_57 · Cited by 1 · see citing works

Phytochemical D-Pinitol Loaded Graphene Oxide-Chitosan-Folic Acid Nanocomposite Induced Apoptosis in Hepatoma Hepg-2 CellsPreprint

Ibrahim, I. A. A., Alzahrani, A., Alanazi, I. M., Shahzad, N., Shahid, I., Falemban, A. H., Azlina, M. F. N., & Arulselvan, P. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4621886 · Cited by 1 · see citing works

Yin-Yang of Oxidative Stress in Pancreatic Cancers

Choudhury, S., Sayed, A. A. A., Dandawate, P. R., & Anant, S. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_104-1

Emerging Interdisciplinary Techniques to Extend ROS Modulation for the Benefit of Chemo-/Radiotherapy in Cancer

Singh, S., Dhankhar, R., Dhull, A. K., & Dahiya, K. (2021) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_57-1

Yin-Yang of Oxidative Stress in Pancreatic Cancers

Choudhury, S., Sayed, A. A. A., Dandawate, P. R., & Anant, S. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_104

Peer Review #1 of "The high expression of MTH1 and NUDT5 predict a poor survival and are associated with malignancy of esophageal squamous cell carcinoma (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.9195v0.1/reviews/1

Peer Review #2 of "The high expression of MTH1 and NUDT5 predict a poor survival and are associated with malignancy of esophageal squamous cell carcinoma (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.9195v0.1/reviews/2

Peer Review #2 of "The high expression of MTH1 and NUDT5 predict a poor survival and are associated with malignancy of esophageal squamous cell carcinoma (v0.2)"

(2020) · PeerJ · doi:10.7287/peerj.9195v0.2/reviews/2

Peer Review #1 of "The high expression of MTH1 and NUDT5 predict a poor survival and are associated with malignancy of esophageal squamous cell carcinoma (v0.2)"

(2020) · PeerJ · doi:10.7287/peerj.9195v0.2/reviews/1

Ischemia-Modified Albumin and Thiol-Disulfide Homeostasis in Metastatic Pancreatic Cancer

Esen, S. A., Oğuz, E. F., ERGÜN, Y., Hastürk, D., Bardakçı, M., UÇAR, G., ŞENDUR, M. A. N., Ateş, İ., Erel, Ö., & Doğan, U. N. C. U. (2022) · Journal of Oncological Sciences · doi:10.37047/jos.2022-93441

Physical Activity and Incident Pancreatic Cancer: Results From the UK Biobank Prospective Cohort

Assarian, B. A., Byrne, C. D., McDonnell, D., & Hamady, Z. Z. R. (2025) · Cureus · doi:10.7759/cureus.78040

Effet de la metformine sur la production des formes réactives de l'oxygène par les macrophages M2 humains et les cellules épithéliales intestinales cancéreuses HCT116

Nassif, R. (2021) · doi:10.70675/25eb5ad3za8e9z4ef0zaf50ze761f2fc5884

Combined assessment of stromal tumor infiltrating lymphocytes and tumor peroxiredoxin 4 expression improved prognostic stratification in postoperative pancreatic cancer patients

Liu, Y., 韩佳, Shioya, A., 焦文鹏, Okuro, M., Ito, T., & Yamada, S. (2026) · Diagnostic Pathology · doi:10.1186/s13000-026-01786-8

Rosindol: A fluorogen for the quantitative measurement of reactive oxygen species in living cellsPreprint

Monnone, A., Nicknish, M., Montezco, J. J. J., Sanganoo, C., Aggarwal, N., Luong, A., Schaus, S. E., & Grinstaff, M. W. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.04.730197

Focus on the Interactive Cooperation Among Mechanotransduction and Biochemical Processes in Pancreatic Ductal Adenocarcinoma Development and Possible Adjuvant Role of Retinoic Acid for Its Treatment: A Narrative Review

Fiorino, S., Hong, W., de Biase, D., Mastrangelo, L., Maccioni, F., Grottesi, A., Ambrosi, F., Pincigher, L., Lari, F., Bergamini, C., et al. (2026) · Cancers · doi:10.3390/cancers18121932

PRDX4 expression potentially links redox adaptation to oncogenic signaling and tumor progression in pancreatic ductal adenocarcinoma

Liu, Y., Han, J., Shioya, A., Oyama, T., Guo, X., Yang, Q., Uramoto, H., & Yamada, S. (2026) · Translational Oncology · doi:10.1016/j.tranon.2026.102865

Reduced Sod2 Expression Promotes the Development of Atypical Flat Lesions and Dysplasia during Pancreatic Ductal Adenocarcinoma Progression

Al-Fahd, S., Al-Khalifa, N., & Al-Turki, O. (2024) · Archive of International Journal of Cancer and Allied Science · doi:10.51847/aii39t3aeo

Mutant K-Ras Mediated Oxidative Stress in Pancreatic Cancer

Thomas, D., Sagar, S., Caffrey, T., & Radhakrishnan, P. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_94-1

A Review of

Kong, B., Qia, C., Erkan, M., Kleeff, J., Michalski, C. W., Stokes, K. Y., State, L., Satoh, K., Cancer, M., & Michalski, C. W. (1993)

Targeted mouse models for preclinical therapy trials

Siveke, J. T. (2014) · Pancreatology · doi:10.1016/j.pan.2014.03.015

Targeting reactive oxygen species in development and progression of pancreatic cancer

Durand, N., & Störz, P. (2016) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2017.1261017 · Cited by 78 · see citing works

Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions

Liou, G.-Y., Döppler, H., DelGiorno, K. E., Zhang, L., Leitges, M., Crawford, H. C., Murphy, M. P., & Storz, P. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.029 · Cited by 270 · see citing works